U.S. Intravenous Immunoglobulin Market Growth Driven by Rising Autoimmune Disorders
The U.S. intravenous immunoglobulin market size is expected to reach USD 10.42 billion by 2030, according to a new report by Grand View Research, Inc. It is estimated to register a CAGR of 7.7% during the forecast period, driven by the rising prevalence of primary and acquired immunodeficiency diseases such as congenital AIDS, and increased adoption of IVIG therapy. There are over 350 chronic...
0 Comments 0 Shares 67 Views 0 Reviews
Sponsored